CClinicalTrials.gg
TerminatedNCT01895647Updated Jul 8, 2019Results posted

Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure

An interventional study of EMS in Severe Sepsis, Acute Respiratory Failure and Muscle Hypotonia, sponsored by Mackay Memorial Hospital. Terminated at 1 site in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-07-08.

Sponsored by Mackay Memorial Hospital · Not applicable, Interventional, and Prevention

Why this study was terminated
slow recruitment and high drop-out rate
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
20 Years to 90 Years
Sex
All
01

Study summary

Rationale : Electric muscle stimulation reduced critical-illness related weakness in patients with severe sepsis and septic shock. But optimal protocol of the stimulation in unknown.

Hypothesis: Focal muscle contraction may improved the muscle power and have systemic anti-inflammatory via cytokine secretion . The difference of electricity used in upper limb or lower limb stimulation may lead to different effect.

Study design: Stratified randomized parallel control study, comparing Biceps, Quadriceps electric muscle stimulation vs. non-stimulation group.

Participant: adult patients with severe sepsis and acute respiratory failure requiring mechanical ventilation.

Intervention: daily stimulation of bilateral Biceps or Quadriceps by programmed electric devices 32 minutes, 5 days/week

Outcome:

  1. Primary outcome: Ventilator-dependent days
  2. Secondary outcome: change of hand drip muscle power/interleukin-1b/interleukin-6/interleukin-8/TNF-alpha
Read the detailed description

Background : Severe sepsis and septic shock remain top cause of admission to intensive care unit. Muscle weakness was found in 70-100% patients with severe sepsis and septic shock because of critical-illness induced polyneuropathy and myopathy. Previous study revealed electric muscle stimulation (EMS) could reduce such muscle weakness and mechanical ventilator-dependent days.

Hypothesis: different electricity may be needed for minimal contraction of upper or lower limb because of their muscle size. Induced muscle contraction may lead to myokine secretion and beneficial metabolic and anti-inflammatory effect. Stimulation on Quadriceps may be better than on Biceps.

Participant: adult(older than 20 years-old) patients with severe sepsis.septic shock and acute respiratory failure post mechanical ventilation.

Design: Stratified ( gender and age >50 years-old) Randomized parallel 3 arms study.

Intervention: Daily stimulation of Biceps of Quadriceps after third days in intensive care unit. Programmed electric stimulation device ( HELEX 573 model, strength aggressive. mode, 45-55Hz 32 minutes per day, voltage 30-70mA)

02

Conditions studied

  • Severe Sepsis
  • Acute Respiratory Failure
  • Muscle Hypotonia
  • Inflammation
  • Weakness

Keywords

  • electric muscle stimulation
  • respiratory failure
  • sepsis
  • interleukin 6
  • interleukin 15
03

In context

Sepsis

1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.

This study's enrollment of 25 is below the median of 105 across 896 interventional studies indexed under Sepsis.

Browse Sepsis studies →

Lead sponsor

Mackay Memorial Hospital is the lead sponsor of 118 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • severe sepsis or septic shock patients with acute respiratory failure more than 3 days
  • adult patients( age>20 years-old)

Exclusion criteria

Exclusion Criteria:

  • skin wound/infection near the site of muscle stimulation
  • acute myocardial infarction within 7 days
  • pregnant women
  • uncontrolled epilepsy
  • no spontaneous breath because of central or cervical spinal neuropathy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Biceps stimulation

    EMS

    Device: EMS

  • Experimental
    Quadriceps stimulation

    EMS

    Device: EMS

  • No intervention
    Control

    Control group without electric muscle stimulation

Interventions

  • DeviceEMS

    Electric muscle stimulation with programmed warm-up, stimulation and cool-down in 32 minutes

    Also known as: HELEX 573

06

What researchers measure

Primary outcomes

  1. Ventilator-dependant Days

    Patient days on mechanical ventilator ( Our National Health Insurance provide 21 days for acute intensive care at most)

    Time frame: 21 days

Secondary outcomes

  1. Muscle Strength Improvement

    muscle power measurement by hand grip digital dynamometer every 2 days

    Time frame: 21 days

Other outcomes

  1. Inflammatory Cytokine Change

    Serum interleukin(IL)-1B, IL-6, IL-8, IL-10, IL-15 and tumor necrosis factor(TNF)-alpha will be measured before/after first section of EMS, and after fifth EMS section.

    Time frame: First 1 week.

07

Results

Posted Jul 8, 2019

Participant flow

Participant flow — Overall Study
MilestoneBiceps StimulationQuadriceps StimulationControl
Started8107
Completed8107
Not completed000

Outcome measures

PrimaryVentilator-dependant Days

Patient days on mechanical ventilator ( Our National Health Insurance provide 21 days for acute intensive care at most)

Time frame:
21 days
Reported as:
Median · days
Ventilator-dependant Days
daysBiceps StimulationQuadriceps StimulationControl
Ventilator-dependant Days6 (5.5 to 7)7 (5 to 11)6 (6 to 15)
SecondaryMuscle Strength Improvement

muscle power measurement by hand grip digital dynamometer every 2 days

Time frame:
21 days

No measurements were reported for this outcome.

Other pre-specifiedInflammatory Cytokine Change

Serum interleukin(IL)-1B, IL-6, IL-8, IL-10, IL-15 and tumor necrosis factor(TNF)-alpha will be measured before/after first section of EMS, and after fifth EMS section.

Time frame:
First 1 week.

No measurements were reported for this outcome.

Adverse events

Collected over The first 2 weeks after EMS applied in the ICU.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Biceps Stimulation2/8 (25%)0/8 (0%)0/8 (0%)
Quadriceps Stimulation3/10 (30%)0/10 (0%)0/10 (0%)
Control2/7 (28.6%)0/7 (0%)0/7 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Biceps StimulationQuadriceps StimulationControlTotal
Median78 (73 to 83)78 (73 to 83)77.5 (72 to 81)78 (72 to 82)
Sex: Female, Male
Sex: Female, Male(Participants)Biceps StimulationQuadriceps StimulationControlTotal
Female58518
Male3227
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Biceps StimulationQuadriceps StimulationControlTotal
Count of participants———0
Region of Enrollment
Region of Enrollment(participants)Biceps StimulationQuadriceps StimulationControlTotal
Taiwan810725
08

Study locations

1 site
  • Mackay Memorial Hospital
    Taipei, 10449, Taiwan
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01895647
Lead sponsor
Mackay Memorial Hospital
Responsible party
Kuang-Hua Cheng, MD (visiting staff of pulmonary medicine, Mackay Memorial Hospital) — Principal investigator
First posted
Jul 10, 2013
Start date
Jun 2013
Primary completion
Sep 2015
Completion
Sep 2015
Results posted
Jul 8, 2019
Last update
Jul 8, 2019

Study contacts

Kuang H Cheng, Msc
principal investigator · Mackay Memorial Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion